Cell cycle arrest is not senescence, Aging, vol.3, issue.2, pp.94-101, 2011. ,
DOI : 10.18632/aging.100281
URL : http://europepmc.org/articles/pmc3082019?pdf=render
Autophagy mediates the mitotic senescence transition, Genes & Development, vol.23, issue.7, pp.798-803, 2009. ,
DOI : 10.1101/gad.519709
URL : http://genesdev.cshlp.org/content/23/7/798.full.pdf
Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence, Cell, vol.113, issue.6, pp.703-716, 2003. ,
DOI : 10.1016/S0092-8674(03)00401-X
URL : https://doi.org/10.1016/s0092-8674(03)00401-x
p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells, The Journal of Experimental Medicine, vol.210, issue.10, pp.2057-2069, 2013. ,
DOI : 10.1073/pnas.0605752103
URL : http://jem.rupress.org/content/jem/210/10/2057.full.pdf
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas, Nature, vol.98, issue.7128, pp.656-660, 2007. ,
DOI : 10.1073/pnas.211053698
Non-Cell-Autonomous Tumor Suppression by p53, Cell, vol.153, issue.2, pp.449-460, 2013. ,
DOI : 10.1016/j.cell.2013.03.020
URL : https://doi.org/10.1016/j.cell.2013.03.020
BRAFE600-associated senescence-like cell cycle arrest of human naevi, Nature, vol.436, issue.7051, pp.720-724, 2005. ,
DOI : 10.1038/nature03890
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion, Nature Cell Biology, vol.11, issue.8, pp.973-979, 2009. ,
DOI : 10.1074/jbc.M408650200
URL : http://europepmc.org/articles/pmc2743561?pdf=render
Senescenceassociated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor, PLoS Biol, vol.6, pp.2853-2868, 2008. ,
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network, Cell, vol.133, issue.6, pp.1019-1031, 2008. ,
DOI : 10.1016/j.cell.2008.03.039
URL : https://doi.org/10.1016/j.cell.2008.03.039
A complex secretory program orchestrated by the inflammasome controls paracrine senescence, Nature Cell Biology, vol.122, issue.8, 2013. ,
DOI : 10.1007/s00401-011-0841-z
URL : http://europepmc.org/articles/pmc3732483?pdf=render
Four faces of cellular senescence, The Journal of Cell Biology, vol.62, issue.4, pp.547-556, 2011. ,
DOI : 10.1038/sj.onc.1201178
URL : http://jcb.rupress.org/content/jcb/192/4/547.full.pdf
Secretion of Vascular Endothelial Growth Factor by Primary Human Fibroblasts at Senescence, Journal of Biological Chemistry, vol.13, issue.40, pp.29568-29574, 2006. ,
DOI : 10.1101/gad.1243304
Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation, Journal of Cell Science, vol.118, issue.3, pp.485-496, 2005. ,
DOI : 10.1242/jcs.01635
URL : http://jcs.biologists.org/content/joces/118/3/485.full.pdf
Senescence and apoptosis: dueling or complementary cell fates?, EMBO reports, vol.15, issue.11, pp.1139-1153, 2014. ,
DOI : 10.15252/embr.201439245
URL : http://embor.embopress.org/content/embor/15/11/1139.full.pdf
p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer, Cancer Cell, vol.21, issue.6, pp.793-806, 2012. ,
DOI : 10.1016/j.ccr.2012.04.027
URL : https://doi.org/10.1016/j.ccr.2012.04.027
Escape from p21-mediated Oncogene-induced Senescence Leads to Cell Dedifferentiation and Dependence on Anti-apoptotic Bcl-xL and MCL1 Proteins, Journal of Biological Chemistry, vol.25, issue.15, pp.12825-12838, 2011. ,
DOI : 10.1016/j.cell.2009.06.034
Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1, Oncotarget, vol.6, issue.1, pp.409-426, 2015. ,
DOI : 10.18632/oncotarget.2774
URL : https://hal.archives-ouvertes.fr/hal-01396743
Senescence versus apoptosis in chemotherapy, Oncotarget, vol.6, issue.7, pp.4551-4553, 2015. ,
DOI : 10.18632/oncotarget.3114
URL : http://doi.org/10.18632/oncotarget.3114
Mcl-1 and tumor cell persistence, Oncotarget, vol.6, issue.1, 2015. ,
DOI : 10.18632/oncotarget.3035
URL : https://doi.org/10.18632/oncotarget.3035
Therapeutic strategy in unresectable metastatic colorectal cancer, Therapeutic Advances in Medical Oncology, vol.22, issue.2, pp.75-89, 2012. ,
DOI : 10.1200/JCO.2001.19.21.4097
URL : http://journals.sagepub.com/doi/pdf/10.1177/1758834011431592
The Marriage of Growth Factor Inhibitors and Chemotherapy: Bliss or Bust?, Journal of Clinical Oncology, vol.27, issue.10, pp.1545-1548, 2009. ,
DOI : 10.1200/JCO.2008.20.3224
Cancer drug resistance: an evolving paradigm, Nature Reviews Cancer, vol.14, issue.10, pp.714-726, 2013. ,
DOI : 10.1093/neuonc/nos158
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR, Nature, vol.15, issue.7388, pp.100-103, 2012. ,
DOI : 10.1016/j.ccr.2009.02.023
URL : https://iris.unito.it/retrieve/handle/2318/126889/19515/Prahallad_AuthorManuscript.pdf
Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies, Trends in Biochemical Sciences, vol.39, issue.10, pp.465-474, 2014. ,
DOI : 10.1016/j.tibs.2014.08.010
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma, Nature, vol.15, issue.7494, pp.118-122, 2014. ,
DOI : 10.1016/j.ccr.2009.02.023
URL : https://iris.unito.it/retrieve/handle/2318/152041/24211/POST_2014-Sun%20et%20al_Reversible%20and%20adaptive_4aperto%20NEW.pdf
AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity, Cancer Cell, vol.19, issue.1, pp.58-71, 2011. ,
DOI : 10.1016/j.ccr.2010.10.031
URL : https://doi.org/10.1016/j.ccr.2010.10.031
The EGFR-STAT3 Oncogenic Pathway Up-regulates the Eme1 Endonuclease to Reduce DNA Damage after Topoisomerase I Inhibition, Cancer Research, vol.68, issue.3, pp.815-825, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-5115
URL : http://cancerres.aacrjournals.org/content/canres/68/3/815.full.pdf
Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy, Genes & Development, vol.26, issue.7, pp.641-650, 2012. ,
DOI : 10.1101/gad.186965.112
Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity, Cancer Research, vol.68, issue.7, pp.2366-2374, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-5783
URL : http://cancerres.aacrjournals.org/content/canres/68/7/2366.full.pdf
Escape from p21-mediated oncogene-induced senescence leads to cell dedifferenciation and dependency on anti-apoptotic Bcl-xL and Mcl1 proteins, J Biol Chem, 2011. ,
Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells, Nature Cell Biology, vol.266, issue.3, pp.245-252, 2001. ,
DOI : 10.1006/abio.1998.2955
Akt-Dependent Phosphorylation of p21Cip1 Regulates PCNA Binding and Proliferation of Endothelial Cells, Molecular and Cellular Biology, vol.21, issue.16, pp.5644-5657, 2001. ,
DOI : 10.1128/MCB.21.16.5644-5657.2001
URL : http://mcb.asm.org/content/21/16/5644.full.pdf
Degradation, Journal of Biological Chemistry, vol.266, issue.12, pp.9684-9689, 2002. ,
DOI : 10.1038/sj.onc.1204132
DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion, Journal of Cell Science, vol.124, issue.1, pp.68-81, 2011. ,
DOI : 10.1242/jcs.071340
URL : http://jcs.biologists.org/content/joces/124/1/68.full.pdf
MEK drives cyclin D1 hyperelevation during geroconversion, Cell Death & Differentiation, vol.4, issue.9, pp.1241-1249, 2013. ,
DOI : 10.4161/cc.21908
URL : http://www.nature.com/cdd/journal/v20/n9/pdf/cdd201386a.pdf
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: Duration of cell cycle arrest and MTOR activity determine geroconversion, Cell Cycle, vol.10, issue.18, pp.3063-3069, 2013. ,
DOI : 10.4161/cc.10.3.14707
Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes., Proceedings of the National Academy of Sciences, vol.90, issue.23, pp.11034-11038, 1993. ,
DOI : 10.1073/pnas.90.23.11034
Requirement for p53 and p21 to Sustain G2 Arrest After DNA Damage, Science, vol.282, issue.5393, pp.1497-1501, 1998. ,
DOI : 10.1126/science.282.5393.1497
Genetic determinants of p53-induced apoptosis and growth arrest., Genes & Development, vol.10, issue.15, pp.1945-1952, 1996. ,
DOI : 10.1101/gad.10.15.1945
URL : http://genesdev.cshlp.org/content/10/15/1945.full.pdf
Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism, Cancer Res, vol.57, pp.4703-4706, 1997. ,
Cell-cycle arrest versus cell death in cancer therapy, Nature Medicine, vol.20, issue.9, pp.1034-1036, 1997. ,
DOI : 10.1101/gad.8.21.2540
The cdk5 Kinase Regulates the STAT3 Transcription Factor to Prevent DNA Damage upon Topoisomerase I Inhibition, Journal of Biological Chemistry, vol.532, issue.35, pp.26765-26778, 2010. ,
DOI : 10.1200/JCO.2008.21.3264
URL : http://www.jbc.org/content/285/35/26765.full.pdf
Inhibition of Mcl-1 Promotes Senescence in Cancer Cells: Implications for Preventing Tumor Growth and Chemotherapy Resistance, Molecular and Cellular Biology, vol.32, issue.10, pp.1879-1892, 2012. ,
DOI : 10.1128/MCB.06214-11
URL : http://mcb.asm.org/content/32/10/1879.full.pdf
Glycogen Synthase Kinase-3 Regulates Mitochondrial Outer Membrane Permeabilization and Apoptosis by Destabilization of MCL-1, Molecular Cell, vol.21, issue.6, pp.749-760, 2006. ,
DOI : 10.1016/j.molcel.2006.02.009
URL : https://doi.org/10.1016/j.molcel.2006.02.009
Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity, Clin Cancer Res, vol.9, pp.2856-2865, 2003. ,
DOI : 10.1042/cs103047pb
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins, Genes & Development, vol.19, issue.11, pp.1294-1305, 2005. ,
DOI : 10.1101/gad.1304105
URL : http://genesdev.cshlp.org/content/19/11/1294.full.pdf
Induction of Noxa Sensitizes Human Colorectal Cancer Cells Expressing Mcl-1 to the Small-Molecule Bcl-2/Bcl-xL Inhibitor, ABT-737, Clinical Cancer Research, vol.14, issue.24, pp.8132-8142, 2008. ,
DOI : 10.1158/1078-0432.CCR-08-1665
URL : http://clincancerres.aacrjournals.org/content/clincanres/14/24/8132.full.pdf
Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction, Biochemical and Biophysical Research Communications, vol.413, issue.3, pp.460-464, 2011. ,
DOI : 10.1016/j.bbrc.2011.08.118
Structural insights into the degradation of Mcl-1 induced by BH3 domains, Proceedings of the National Academy of Sciences, vol.98, issue.2, pp.6217-6222, 2007. ,
DOI : 10.1021/j100058a043
URL : http://www.pnas.org/content/104/15/6217.full.pdf
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer, Oncogene, vol.104, issue.34, pp.4741-4751, 2010. ,
DOI : 10.1016/S0002-9440(10)65297-2
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells, Cell, vol.133, issue.4, pp.704-715, 2008. ,
DOI : 10.1016/j.cell.2008.03.027
Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis, Journal of Clinical Oncology, vol.26, issue.17, pp.2839-2845, 2008. ,
DOI : 10.1200/JCO.2007.15.1829
Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells?, International Journal of Cancer, vol.18, issue.10, pp.2310-2314, 2011. ,
DOI : 10.1016/j.ccr.2010.10.012
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.26311/pdf
Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells, PLoS ONE, vol.77, issue.4, p.94621, 2014. ,
DOI : 10.1371/journal.pone.0094621.s004
Tumor Stroma-Derived TGF-?? Limits Myc-Driven Lymphomagenesis via Suv39h1-Dependent Senescence, Cancer Cell, vol.17, issue.3, pp.262-272, 2010. ,
DOI : 10.1016/j.ccr.2009.12.043
URL : https://doi.org/10.1016/j.ccr.2009.12.043
Development of PI3K inhibitors: lessons learned from early clinical trials, Nature Reviews Clinical Oncology, vol.72, issue.3, pp.143-153, 2013. ,
DOI : 10.1158/1538-7445.AM2012-CT-02
Pharmacokinetic assessment of irinotecan, SN-38, and SN-38-glucuronide: a substudy of the FIRIS study, Anticancer Res, vol.33, pp.3845-3853, 2013. ,